\relax 
\providecommand\hyper@newdestlabel[2]{}
\providecommand\HyperFirstAtBeginDocument{\AtBeginDocument}
\HyperFirstAtBeginDocument{\ifx\hyper@anchor\@undefined
\global\let\oldcontentsline\contentsline
\gdef\contentsline#1#2#3#4{\oldcontentsline{#1}{#2}{#3}}
\global\let\oldnewlabel\newlabel
\gdef\newlabel#1#2{\newlabelxx{#1}#2}
\gdef\newlabelxx#1#2#3#4#5#6{\oldnewlabel{#1}{{#2}{#3}}}
\AtEndDocument{\ifx\hyper@anchor\@undefined
\let\contentsline\oldcontentsline
\let\newlabel\oldnewlabel
\fi}
\fi}
\global\let\hyper@last\relax 
\gdef\HyperFirstAtBeginDocument#1{#1}
\providecommand*\HyPL@Entry[1]{}
\AC@reset@newl@bel
\HyPL@Entry{0<</S/D>>}
\providecommand\tcolorbox@label[2]{}
\citation{arruda_genetic_2015}
\citation{arruda_genetic_2015}
\citation{mcaleer_severe_2015}
\citation{mcaleer_severe_2015}
\citation{verhoeven_hematopoietic_2022}
\citation{verhoeven_hematopoietic_2022}
\citation{magerus-chatinet_autoimmune_2013}
\citation{magerus-chatinet_autoimmune_2013}
\citation{sharfe_fatal_2014}
\citation{sharfe_fatal_2014}
\newlabel{Supplemental_text}{{}{2}{Supplemental}{section*.1}{}}
\@writefile{lot}{\contentsline {table}{\numberline {S1}{\ignorespaces \textbf  {Summary of case study queries and PanelAppRex results.} ``Subjective best panels'' are those reasonably preferable to the clinical query and unlikely to be excluded by users. In the benchmark scenario, broad or less relevant panels (e.g. ``COVID-19 research'') might be deprioritised in favour of more clinically aligned options such as ``Fetal anomalies'', or ``Paediatric disorders''. Summarised in \textbf  {Figure 1}. *Case study 5 had five individual cases and patient information was significantly longer than other studies. Therefore, we used OpenAI model o3-mini to converted it to a standardised keyword query automatically, thereby removing our subjective bias and aligning with the other queries. }}{2}{table.1}}
\newlabel{tab:benchmark}{{S1}{2}{\textbf {Summary of case study queries and PanelAppRex results.} ``Subjective best panels'' are those reasonably preferable to the clinical query and unlikely to be excluded by users. In the benchmark scenario, broad or less relevant panels (e.g. ``COVID-19 research'') might be deprioritised in favour of more clinically aligned options such as ``Fetal anomalies'', or ``Paediatric disorders''. Summarised in \textbf {Figure 1}. *Case study 5 had five individual cases and patient information was significantly longer than other studies. Therefore, we used OpenAI model o3-mini to converted it to a standardised keyword query automatically, thereby removing our subjective bias and aligning with the other queries}{table.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {S1}{\ignorespaces \textbf  {Validation and recovery of core annotation fields in the PanelAppRex dataset.} (A) Unique genes and HGNC IDs before and after retrieving missing HGNC entries via Ensembl. (B) Availability of publication annotations for genes. (C) Unique genes and Ensembl gene IDs before and after biomart-based recovery of missing Ensembl IDs. (D) Gene entries with associated disease panel names. (E) Gene entries with annotated \ac {moi}. (F) Gene entries linked to an OMIM gene ID. Each bar shows the count of entries with non-missing values for the respective field. Updated fields (HGNC and Ensembl ID) reflect values recovered via external lookup using HGNC symbols. Percentage shows the complete recovery of coverage across features. }}{3}{figure.1}}
\acronymused{moi}
\newlabel{fig:validation}{{S1}{3}{\textbf {Validation and recovery of core annotation fields in the PanelAppRex dataset.} (A) Unique genes and HGNC IDs before and after retrieving missing HGNC entries via Ensembl. (B) Availability of publication annotations for genes. (C) Unique genes and Ensembl gene IDs before and after biomart-based recovery of missing Ensembl IDs. (D) Gene entries with associated disease panel names. (E) Gene entries with annotated \ac {moi}. (F) Gene entries linked to an OMIM gene ID. Each bar shows the count of entries with non-missing values for the respective field. Updated fields (HGNC and Ensembl ID) reflect values recovered via external lookup using HGNC symbols. Percentage shows the complete recovery of coverage across features}{figure.1}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {S2}{\ignorespaces \textbf  {Summary of gene confidence levels, reuse across panels, and panel sizes in the PanelAppRex dataset.} (A) Number of genes per confidence level. (B) Number of panels in which each gene is included, with the example gene \textit  {RAG1} highlighted to demonstrate that it is present in 7 panels. (C) Number of genes per panel, with two representative panels annotated: panel ID 398 (\ac {pid}/\ac {iei}) and panel ID 1220 (\ac {iem}). }}{4}{figure.2}}
\acronymused{pid}
\acronymused{iei}
\acronymused{iem}
\newlabel{fig:summary_stats}{{S2}{4}{\textbf {Summary of gene confidence levels, reuse across panels, and panel sizes in the PanelAppRex dataset.} (A) Number of genes per confidence level. (B) Number of panels in which each gene is included, with the example gene \textit {RAG1} highlighted to demonstrate that it is present in 7 panels. (C) Number of genes per panel, with two representative panels annotated: panel ID 398 (\ac {pid}/\ac {iei}) and panel ID 1220 (\ac {iem})}{figure.2}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {S3}{\ignorespaces \textbf  {Summary of mode of inheritance annotations in the PanelAppRex dataset.} (A) Counts of unique genes annotated with each \ac {moi}, based on non-redundant gene-\ac {moi} combinations. (B) Total number of unique genes and total number of gene-\ac {moi} combinations in the harmonised PanelAppRex dataset. }}{5}{figure.3}}
\acronymused{moi}
\acronymused{moi}
\acronymused{moi}
\newlabel{fig:uniq_gene_moi}{{S3}{5}{\textbf {Summary of mode of inheritance annotations in the PanelAppRex dataset.} (A) Counts of unique genes annotated with each \ac {moi}, based on non-redundant gene-\ac {moi} combinations. (B) Total number of unique genes and total number of gene-\ac {moi} combinations in the harmonised PanelAppRex dataset}{figure.3}{}}
\@writefile{lof}{\contentsline {figure}{\numberline {S4}{\ignorespaces \textbf  {(logo)} PanelAppRex reigns over genomic complexity. }}{5}{figure.4}}
\newlabel{fig:uniq_gene_moi}{{S4}{5}{\textbf {(logo)} PanelAppRex reigns over genomic complexity}{figure.4}{}}
\bibstyle{unsrtnat}
\bibdata{references.bib}
\bibcite{arruda_genetic_2015}{{1}{2015}{{Arruda et~al.}}{{Arruda, Delcaro, Botelho~Palhas, Dias, Muglia, Castelli, Bork, and Moreno}}}
\bibcite{mcaleer_severe_2015}{{2}{2015}{{McAleer et~al.}}{{McAleer, Pohler, Smith, Wilson, Cole, MacGowan, Koetsier, Godsel, Harmon, Gruber, Crumrine, Elias, McDermott, Butler, Broderick, Sarig, Sprecher, Green, McLean, and Irvine}}}
\bibcite{verhoeven_hematopoietic_2022}{{3}{2022}{{Verhoeven et~al.}}{{Verhoeven, Schonenberg-Meinema, Ebstein, Papendorf, Baars, Van~Leeuwen, Jansen, Lankester, Van Der~Burg, Florquin, Maas, Van~Koningsbruggen, Kr√ºger, Van Den~Berg, and Kuijpers}}}
\bibcite{magerus-chatinet_autoimmune_2013}{{4}{2013}{{Magerus-Chatinet et~al.}}{{Magerus-Chatinet, Stolzenberg, Lanzarotti, Neven, Daussy, Picard, Neveux, Desai, Rao, Ghosh, Madkaikar, Fischer, and Rieux-Laucat}}}
\bibcite{sharfe_fatal_2014}{{5}{2014}{{Sharfe et~al.}}{{Sharfe, Nahum, Newell, Dadi, Ngan, Pereira, Herbrick, and Roifman}}}
